S. Korea approves Pfizer's COVID vaccine for ages 5-11

S.Korea approves Pfizer COVID-19 vaccine for children aged 5-11

SEOUL (Reuters) – South Korea has approved Pfizer’s COVID-19 vaccine for use with children aged 5-11, the country’s food and drug ministry said on Wednesday.Children should get one-third of the regular dose, twice with a three week interval, the ministry said in a statement. Children with significantly declined immunity can get a booster four weeks later.

Covid live: Poland, Slovakia and Iceland latest countries set to end most coronavirus restrictions

Move comes as case numbers and deaths continue to fall in many nations

South Korea approves Pfizer's Covid vaccine for ages 5-11

Rest of World News: SEOUL: South Korean health officials on Wednesday approved Pfizer's Covid-19 vaccine for children aged 5 to 11, expanding the country's immunization p.

South Korea approves Pfizer's COVID vaccine for ages 5-11

The Korea Disease Control and Prevention Agency reported a record 171,452 new virus cases on Wednesday, nearly a 40-fold increase from levels in mid-January when omicron first emerged as the country’s dominant strain.

S. Korea approves Pfizer's COVID vaccine for ages 5-11

South Korean health officials on Wednesday approved Pfizer’s COVID-19 vaccine for children aged 5 to 11, expanding the country's immunization program in the face of a massive omicron outbreak that is driving up hospitalizations and deaths.The Korea Disease Control and Prevention Agency reported a record 171,452 new virus cases on Wednesday, nearly a 40-fold increase from levels in mid-January when omicron first emerged as the country’s dominant …

S. Korea approves Pfizer's COVID vaccine for ages 5-11

South Korean health officials on Wednesday approved Pfizer’s COVID-19 vaccine for children aged 5 to 11, expanding the country's immunization program in the face of a massive omicron outbreak that is driving up hospitalizations and deaths.The Korea Disease Control and Prevention Agency reported a record 171,452 new virus cases on Wednesday, nearly a 40-fold increase from levels in mid-January when omicron first emerged as the country’s dominant …